These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10405547)

  • 1. Multidrug therapy.
    Lynch P
    Lepr Rev; 1999 Mar; 70(1):70-1. PubMed ID: 10405547
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposal regarding MB MDT.
    Van Brakel WH
    Lepr Rev; 1999 Mar; 70(1):71-3. PubMed ID: 10405548
    [No Abstract]   [Full Text] [Related]  

  • 3. Multidrug therapy: reply to letters.
    Ji B
    Lepr Rev; 1999 Sep; 70(3):367-8. PubMed ID: 10603729
    [No Abstract]   [Full Text] [Related]  

  • 4. Uniform MDT (U-MDT) regimen for all leprosy patients--another example of wishful thinking.
    Ji B; Saunderson P
    Lepr Rev; 2003 Mar; 74(1):2-6. PubMed ID: 12669926
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
    Pattyn S; Grillone S
    Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shortening duration of treatment of multibacillary leprosy. Action Programme for the Elimination of Leprosy, WHO.
    Indian J Lepr; 1997; 69(3):267-70. PubMed ID: 9394176
    [No Abstract]   [Full Text] [Related]  

  • 8. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Kars HK
    Indian J Lepr; 1998; 70(2):214-5; author reply 219-21. PubMed ID: 9724859
    [No Abstract]   [Full Text] [Related]  

  • 9. Gender differences in epidemiological factors associated with treatment completion status of leprosy patients in the most hyperendemic district of Nepal.
    Kumar RB; Singhasivanon P; Sherchand JB; Mahaisavariya P; Kaewkungwal J; Peerapakorn S; Mahotarn K
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):334-9. PubMed ID: 15691132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the incidence of type 2 reactions in lepromatous leprosy with two regimens of treatment.
    Manungo J; Thomas JE
    Cent Afr J Med; 1982 Sep; 28(9):209-11. PubMed ID: 7151141
    [No Abstract]   [Full Text] [Related]  

  • 11. Whither short-course chemotherapy for leprosy?
    Grosset J
    Indian J Lepr; 1997; 69(2):119-20. PubMed ID: 9290962
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term follow-up of ROM treated cases.
    Alam K; Butlin CR; Pahan D; Kumar S; Chowdhury
    Lepr Rev; 2007 Jun; 78(2):160. PubMed ID: 17824488
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment: ulnar abscess--4 months after release from control with paucibacillary-multidrug therapy.
    Salafia A; Chuhan G
    Lepr Rev; 1998 Mar; 69(1):87-8. PubMed ID: 9628100
    [No Abstract]   [Full Text] [Related]  

  • 14. Multidrug therapy in paucibacillary leprosy.
    Jopling WH
    Lepr Rev; 1990 Dec; 61(4):391. PubMed ID: 2280662
    [No Abstract]   [Full Text] [Related]  

  • 15. Implementation of multidrug therapy for leprosy control programmes.
    Porichha D
    Lepr Rev; 1990 Dec; 61(4):392-3. PubMed ID: 2280664
    [No Abstract]   [Full Text] [Related]  

  • 16. Relapse rates amongst the multidrug therapy-treated leprosy patients.
    Umarane SB
    Indian J Lepr; 2001; 73(4):362-4. PubMed ID: 11898471
    [No Abstract]   [Full Text] [Related]  

  • 17. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symposium on multidrug therapy in leprosy. 24-26 April 1986, Würburg, West Germany. Proceedings.
    Lepr Rev; 1986; 57 Suppl 3():1-288. PubMed ID: 3573948
    [No Abstract]   [Full Text] [Related]  

  • 19. Multidrug therapeutic challenges in leprosy.
    Jain S; Sehgal VN
    Int J Dermatol; 1997 Jul; 36(7):493-6. PubMed ID: 9268743
    [No Abstract]   [Full Text] [Related]  

  • 20. [Implementing WHO/multi drug treatment for leprosy].
    Obara A
    Nihon Hansenbyo Gakkai Zasshi; 1998 Jul; 67(2):345-51. PubMed ID: 9785849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.